| Literature DB >> 35814234 |
Junying Pan1, Haoyu Wang1, Yinghua Chen1.
Abstract
Prunella vulgaris L. (PVL) is dried fruit spike of Lamiacea plant Prunella vulgaris L., which is a perennial herb with medicinal and edible homology used for thousands of years. PVL is bitter, acrid, cold, and belongs to the liver and gallbladder meridians. It clears the liver and dissipate fire, improve vision, disperse swelling, and has satisfactory clinical therapeutic effects on many diseases such as photophobia, dizziness, scrofula, goiter, breast cancer. The collection of information and data related to PVL comes from literatures retrieved and collated from various online scientific databases (such as CNKI, VIP, PubMed, Web of Science, Research Gate, Science Database), ancient books of traditional chinese medicine (Encyclopedia of Traditional Chinese Medicine, Classics of Traditional Chinese Medicine, Dictionary of Traditional Chinese Medicine), and Doctoral and Master's Dissertations. Currently, the major chemical constituents isolated and identified from PVL are triterpenoids, steroids, flavonoids, phenylpropanoids, organic acids, volatile oils and polysaccharides. Modern pharmacological studies have shown that PVL has a wide range of pharmacological activities, including anti-inflammatory, anti-tumor, antibacterial and antiviral effects, as well as immune regulation, antihypertensive, hypoglycemic, lipid-lowering, antioxidant, free radical scavenging, liver protection, sedative and hypnotic effects. This paper reviewes the botany, ethnopharmacology, traditional application, phytochemistry, analytical methods, quality control, pharmacological effects of PVL. It can be used not only as medicine, but also gradually integrated into the "medicine and food homology" and "Chinese medicine health" boom. More importantly, it has great potential for drug resources development. This paper deeply discusses the shortcomings of current PVL research, and proposes corresponding solutions, in order to find a breakthrough point for PVL research in the future. At the same time, it is necessary to further strengthen the research on its medicinal chemistry, mechanism of action and clinical application efficacy in the future, and strive to extract, purify and synthesize effective components with high efficiency and low toxicity, so as to improve the safety and rationality of clinical medication.Entities:
Keywords: Prunella vulgaris L.; analytical methods; chemical constituents; ethnopharmacology; pharmacological effects; quality control; traditional applications
Year: 2022 PMID: 35814234 PMCID: PMC9261270 DOI: 10.3389/fphar.2022.903171
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Aerial parts and dry spikes of Prunella vulgaris L. (Global Biodiversity Information Facility).
Chemical structures of triterpenes isolated from PVL─Part I.
| Groups | R1 | R2 | R3 | R4 | R5 | R6 | |
|---|---|---|---|---|---|---|---|
|
| (26) Methyl ursolate | H | βOH | Me | Me | Me | H |
| (28) Methyl oleanolate | H | βOH | Me | Me | H | Me | |
| (73) Methyl 2α,3α-dihydroxyurs-12-en-28-oate | OH | αOH | Me | Me | Me | H | |
| (32) Methyl 3-epimaslinate | OH | αOH | Me | Me | H | Me | |
| (75) Methyl 2 | OH | αOH | Me | CH2OH | Me | H | |
| (33) Methyl 2α-hydroxyursolate | OH | βOH | Me | Me | Me | H | |
| (29) Methyl maslinate | OH | βOH | Me | Me | H | Me | |
| (76) Methyl 2α,3α,23-trihydroxyolean-12-en-28-oate | OH | αOH | CH2OH | Me | H | Me | |
| (Kojima and Ogura) | (77) Methyl 2α,3α,24-trihydroxyolean-12-en-28-oate | OH | αOH | Me | CH2OH | H | Me |
Chemical structures of triterpenes isolated from PVL─Part VI.
| Groups | R1 | R2 | R3 | R4 | R5 | R6 | |
|---|---|---|---|---|---|---|---|
|
| (52) 2α,3α-24-trihydroxyursa-12-en-28-oic acid-28-O-β-D-glucopyranoside | OH | αOH | CH2OH | Glc | H | CH3 |
| (70) 2α,3β,19α,24-tetrahydroxyurs-12-en-28-oic acid-28-β-D-glucopyranoside | OH | βOH | CH2OH | Glc | OH | CH3 | |
| (55) 2α,3α,19α-trihydroxyurs-12-en-28-oic acid-28-β-D-glucopyranoside | OH | αOH | CH3 | Glc | OH | CH3 | |
| (56) 2α,3α,19α-trihydroxyurs-12-en-28-oic acid-28-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside | OH | αOH | CH3 | Glc (1–2)Glc | OH | CH3 | |
| (Yu et al.) | (82) Rotundic acid 28-O-α-D-glueopyranosyl (1→6)-β-D-glueopyranoside | H | βOH | CH3 | Glc (1–6)Glc | OH | OH |
Chemical structures of sterols isolated from PVL.
|
|
|
|
| (95) Stigmast-7-enol | (91) | (89) Spinasterone |
|
|
|
|
| (93) | (88) Stigmasterol | (96) Stigmast-7-en-3 |
|
|
|
|
| (90) Daucosterol | (97) Qingyangshengenin-3- | (98) Qinyangshengenin-3- |
Chemical structures of flavonoids isolated from PVL.
|
|
|
|
| (132) Quercetin | (134) Luteolin | (136) Wogonin |
|
|
|
|
| (130) Rutin | (137) Homoorientin | (135) Cynaroside |
|
|
|
|
| (143 ) Quercetin-3- | (145) Kaempferol-3- | (133) Quercitrin |
|
| ||
| (138) Hesperidin |
Chemical structures of phenylpropanoids isolated from PVL.
|
|
|
|
| (107) Umbelliferone | (106) Scopoletin | (108) Esculetin |
|
|
|
|
| (109) Coniferaldehyde | (117) Sinapaldehyde | (123) 4-allyl-2,6-dimethoxyphenol |
|
|
|
|
| (103) Ethyl caffeate | (126) 3,4, | (120) Danshensu |
|
|
|
|
| (127) 3,4, α-trihydroxy-methyl phenylpropionate | (102) Chlorogenic acid | (101) Caffeic acid |
|
|
|
|
| (116) Salviaflaside | (112) Rosmarinic acid | (128) (-)-syringaresinol-4- |
|
|
|
|
| (115) Ethyl rosmarinate | (114) Butyl rosmarinate | (113) Methyl rosmarinate |
Chemical structures of volatile oils isolated from PVL.
|
|
|
|
|
|
| (191) | (192) | (199) | (189) | (223) 1,8-Cineol |
|
|
|
|
|
|
| (205) | (216) Bornyl acetate | (200) Vanillin | (197) | (215) Methyl salicylate |
|
|
|
|
|
|
| (111) 3,4-Dihydrocoumarin | (110) Coumarin | (194) | (193) | (206) 4-Vinylguaiacol |
|
|
|
|
|
|
| (237) Selin-11-en-4- | (184) Spathulenol | (182) (-)-Thujopsen | (196) | (202) Sinapaldehyde |
|
|
|
|
|
|
| (195) | (188) | (190) | (183) Germacrene D | (198) |
|
|
|
|
|
|
| (181) Cuparene | (188) | (185) | (186) | (204) Ferruginol |
Chemical structures of triterpenes isolated from PVL─Part II.
| Groups | R1 | R2 | R3 | R4 | |
|---|---|---|---|---|---|
|
| (22) Pruvuloside A | αOH | CH3 | CH3 | Glc2-Glc |
| (19) Niga-ichigoside F1 | βOH | CH2OH | CH3 | Glc | |
| (20) Niga-ichigoside F2 | αOH | CH2OH | CH3 | Glc | |
| (Zhang and Yang) | (23) Pruvuloside B | αOH | CH3 | CH2OH | Glc |
Chemical structures of triterpenes isolated from PVL─Part III.
| Groups | R1 | R2 | R3 | |
|---|---|---|---|---|
|
| (45) 2 | CH2OH | CH3 | CH2 |
| (49) 2 | CH2OH | H | CH3CH2CH3 | |
| (51) 2 | CH2OH | CH3 | CH3CH3 | |
| (61) 2 | H | H | CH3CH2CH3 | |
| (Wang et al.) | (62) 2 | H | CH3 | CH3CH3 |
Chemical structures of triterpenes isolated from PVL─Part IV.
| Groups | R1 | R2 | R3 | R4 | R5 | R6 | R7 | R8 | R9 | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| (3) Maslinic acid | αOH | αOH | CH3 | CH3 | H | CH3 | αOH | CH3 | H |
| (48) 2 | αOH | βOH | CH3 | CH3 | H | H | H | CH3 | CH3 | |
| (54) 2 | αOH | αOH | CH2OH | CH3 | H | CH3 | αOH | CH3 | H | |
| (57) 2 | αOH | αOH | CH2OH | CH3 | H | CH3 | H | CH3 | H | |
| (59) 2 | αOH | βOH | CH2OH | CH3 | Glc | CH3 | αOH | CH3 | H | |
| (Lee et al.) | (69) 2 | αOH | αOH | CH2OH | CH3 | Glc | CH3 | αOH | CH3 | H |
Chemical structures of triterpenes isolated from PVL─Part V.
| Groups | R1 | R2 | R3 | R4 | R5 | R6 | R7 | R8 | R9 | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| (84) 2,3,24-trihydroxyolean-12-en-28-oic acid | OH | OH | CH3 | CH2OH | CH3 | CH3 | H | H | H |
| (83) 2,3,24-trihydroxyurs-12-en-28-oic acid | OH | OH | CH3 | CH2OH | CH3 | H | H | CH3 | H | |
| (42) 3β,22α-dihydroxyolean-12-en-28-oic acid | H | βOH | CH3 | CH3 | CH3 | CH3 | H | H | αOH | |
| (43) 3β,22α-dihydroxyurs-12-en-28-oic acid | H | βOH | CH3 | CH3 | CH3 | H | H | CH3 | αOH | |
| (Yang et al.) | (87) 22-hydroxy-3-oxoleana-12-en-28-oic acid | H | =O | CH3 | CH3 | CH3 | CH3 | H | H | H |